血液学和生化学参数对沙丘病的临床过程的预测影响
Tugba Onyilmaz1, Serap Argun Baris1, Huseyin Kaya2
1Department of Chest Diseases, University of Kocaeli, 41001 Kocaeli, Turkey.
Diagnostics (Basel, Switzerland)
|October 16, 2025
概括
乳酸脱酶与蛋白的比率 (LAR) 可以预测型硬化症的进展. 在患有疾病进展的患者中观察到较高的LAR水平,这表明它有可能成为沙尔科毒症的预后生物标志物.
科学领域:
- 肺部医学 肺部医学
- 生物标志物 生物标志物
- 系统性粒状体疾病 系统性粒状体疾病
背景情况:
- 石病是一种复杂的系统性颗粒性疾病,具有不可预测的临床轨迹.
- 准确的预后和与其他疾病的区别仍然具有挑战性.
- 血液学和生化标志物正在探索其预后潜力.
研究的目的:
- 为了研究乳酸脱酶与白蛋白比率 (LAR),中性粒细胞与淋巴细胞比率 (NLR),血小板与淋巴细胞比率 (PLR) 和淋巴细胞与单细胞比率 (LMR) 的预后价值.
- 确定可靠的生物标志物,用于预测疾病的过程和进展.
主要方法:
- 对369名新诊断的沙尔科病患者进行了回顾性分析.
- 临床过程的分类 (回归,稳定,进展) 在6个月的随访.
- 统计分析包括后勤回归和ROC分析,以评估生物标志物的预测值.
主要成果:
- 与稳定/回归组相比,疾病进展组的LAR显著更高 (p=0.033).
- 基线FVC%和呼吸障碍的存在被确定为进展的独立风险因素.
- 在NLR,PLR,LMR或血清ACE水平和临床过程之间没有发现显著的关联.
结论:
- 乳酸脱酶与蛋白的比率 (LAR) 是沙尔科毒症临床过程的重要指标.
- 升高的LAR水平显示出潜力作为一种预后生物标志物,用于类病的进展.
- 需要进一步的前性研究来验证LAR在指导治疗和随访中的作用.
相关概念视频
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K

